| 1 | Alphabet Inc | 31.127 | 9 Mio. $ | |
| 2 | ASE Technology Holding Co Ltd | 179.512 | 3,9 Mio. $ | |
| 3 | Ionis Pharmaceuticals Inc | 38.988 | 2,9 Mio. $ | |
| 4 | Neurocrine Biosciences Inc | 21.556 | 2,8 Mio. $ | |
| 5 | Axsome Therapeutics Inc | 16.401 | 2,8 Mio. $ | |
| 6 | BioMarin Pharmaceutical Inc | 48.719 | 2,8 Mio. $ | |
| 7 | Ascendis Pharma A/S | 11.828 | 2,7 Mio. $ | |
| 8 | PTC Therapeutics Inc | 39.701 | 2,7 Mio. $ | |
| 9 | Pfizer Inc | 71.313 | 2 Mio. $ | |
| 10 | Regeneron Pharmaceuticals, Inc. | 2.502 | 1,9 Mio. $ | |
| 11 | Johnson & Johnson | 7.902 | 1,9 Mio. $ | |
| 12 | Amgen Inc | 4.934 | 1,7 Mio. $ | |
| 13 | Gilead Sciences Inc | 11.961 | 1,7 Mio. $ | |
| 14 | Vertex Pharmaceuticals Inc | 3.412 | 1,5 Mio. $ | |
| 15 | UnitedHealth Group Inc | 5.216 | 1,4 Mio. $ | |
| 16 | Praxis Precision Medicines Inc | 3.855 | 1,2 Mio. $ | |
| 17 | Insmed Inc | 7.018 | 1,1 Mio. $ | |
| 18 | Protagonist Therapeutics Inc | 9.334 | 983.804 $ | |
| 19 | Belite Bio Inc | 6.004 | 957.278 $ | |
| 20 | iShares MSCI Taiwan ETF | 12.500 | 886.500 $ | |
| 21 | Moderna Inc | 17.097 | 868.528 $ | |
| 22 | Biogen Inc | 4.706 | 862.751 $ | |
| 23 | Teva Pharmaceutical Industries Ltd | 25.805 | 777.247 $ | |
| 24 | Revolution Medicines Inc | 7.971 | 775.180 $ | |
| 25 | State Street Utilities Select Sector SPDR ETF | 16.400 | 752.596 $ | |
| 26 | Octave Specialty Group Inc | 139.168 | 647.131 $ | |
| 27 | Twist Bioscience Corp | 13.476 | 640.380 $ | |
| 28 | Madrigal Pharmaceuticals Inc | 1.192 | 623.976 $ | |
| 29 | iShares Trust | 7.100 | 615.499 $ | |
| 30 | BioNTech SE | 6.890 | 612.383 $ | |
| 31 | Natera Inc | 2.970 | 593.970 $ | |
| 32 | Axogen Inc | 16.273 | 539.124 $ | |
| 33 | Select Sector Spdr Trust | 3.300 | 533.709 $ | |
| 34 | Cogent Biosciences Inc | 13.784 | 530.546 $ | |
| 35 | Select Sector Spdr Trust | 8.500 | 520.710 $ | |
| 36 | Select Sector Spdr Trust | 6.300 | 516.474 $ | |
| 37 | Cytokinetics Inc | 7.388 | 486.943 $ | |
| 38 | Genmab A/S | 16.030 | 430.085 $ | |
| 39 | Bridgebio Pharma Inc | 5.785 | 429.594 $ | |
| 40 | Tango Therapeutics Inc | 20.463 | 428.086 $ | |
| 41 | Cooper Cos Inc/The | 5.896 | 421.564 $ | |
| 42 | Eli Lilly & Co | 442 | 406.538 $ | |
| 43 | Erasca Inc | 24.847 | 402.024 $ | |
| 44 | Lumentum Holdings Inc | 562 | 394.951 $ | |
| 45 | Illumina Inc | 3.026 | 372.985 $ | |
| 46 | BioAge Labs Inc | 20.796 | 363.722 $ | |
| 47 | Apogee Therapeutics Inc | 4.007 | 337.269 $ | |
| 48 | ImmunityBio Inc | 41.005 | 314.508 $ | |
| 49 | United Therapeutics Corp | 527 | 312.500 $ | |
| 50 | Dyne Therapeutics Inc | 17.213 | 312.072 $ | |
| 51 | Spyre Therapeutics Inc | 6.140 | 309.702 $ | |
| 52 | Tyra Biosciences Inc | 8.075 | 309.273 $ | |
| 53 | Select Sector Spdr Trust | 6.200 | 306.094 $ | |
| 54 | State Street SPDR S&P 500 ETF Trust | 420 | 273.143 $ | |
| 55 | Alumis Inc | 12.031 | 265.043 $ | |
| 56 | Oruka Therapeutics Inc | 5.147 | 252.460 $ | |
| 57 | Equitable Holdings Inc | 6.794 | 252.125 $ | |
| 58 | Franklin Templeton ETF Trust | 3.700 | 252.007 $ | |
| 59 | Summit Therapeutics Inc | 12.136 | 230.099 $ | |
| 60 | Envista Holdings Corp | 9.001 | 228.355 $ | |
| 61 | CG oncology Inc | 3.370 | 228.082 $ | |
| 62 | Dexcom Inc | 3.628 | 227.838 $ | |
| 63 | Nektar Therapeutics | 2.830 | 203.619 $ | |
| 64 | Structure Therapeutics Inc | 4.190 | 201.958 $ | |
| 65 | Verastem Inc | 36.170 | 191.701 $ | |
| 66 | VanEck Gold Miners ETF/USA | 2.000 | 183.540 $ | |
| 67 | Climb Bio Inc | 24.590 | 168.442 $ | |
| 68 | United States Antimony Corp | 11.426 | 99.749 $ | |
| 69 | Alphabet Inc | 300 | 86.058 $ | |
| 70 | Iovance Biotherapeutics Inc | 19.760 | 69.358 $ | |
| 71 | Neumora Therapeutics Inc | 16.000 | 31.200 $ | |
| 72 | Brandywine Realty Trust | 10.700 | 28.997 $ | |
| 73 | SELECT SECTOR SPDR TRUST (THE) | 200 | 26.580 $ | |
| 74 | Plug Power Inc | 11.208 | 25.330 $ | |
| 75 | iShares Trust | 500 | 23.420 $ | |
| 76 | KraneShares CSI China Internet ETF | 400 | 11.372 $ | |